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review
Hao Wang and Ping Chen*Abstract
Cases of primary colorectal adenocarcinoma metastasized to the palatine tonsil are extremely rare. To the best of
our knowledge, only 10 cases have thus far been previously documented in the English literature. A 37-year-old
Chinese woman presented with a right palatine tonsil swelling and odynophagia 5 months after a surgical
resection of rectal adenocarcinoma was performed. The patient underwent a tonsillectomy, and a metastatic poorly
differentiated adenocarcinoma from a colorectal origin was revealed by immunohistochemical analysis. The manner
in which tonsillar metastases are involved remains unknown and should be further studied. Here, we report a new
case, briefly summarize these 10 cases and review the literature.
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The most common sites of distant metastases from pri-
mary colorectal carcinoma are in the liver, lung, and
brain, and less commonly in the bone, ovary, and ad-
renal gland. Metastasis to palatine tonsil from a primary
colorectal carcinoma is an extremely rare event. Only 10
cases have thus far been previously documented in the
English literature. Hematogenous dissemination is a
probable explanation for the mechanism of metastasis to
the palatine tonsils [1], as well as the suggestion of a
retrograde cervical lymphatic spread through the thor-
acic duct [2].
A metastatic tumor in an unusual site may sometimes
be troublesome to distinguish between a synchronous or
metachronous primary cancer and a metastatic disease,
especially when it is asymptomatic. In this paper, we re-
port the case of a 37-year-old Chinese woman with a
metastasis to the right palatine tonsil from a rectal
adenocarcinoma and review the literature.Case presentation
A 37-year-old Chinese woman was evaluated for right
tonsil swelling and a sore throat in our hospital. She was* Correspondence: chen86ky@126.com
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distribution, and reproduction in any mediumdiagnosed in September 2011 with rectal cancer revealed
by generalized peritonitis evoked by tumor perforation.
At diagnosis, the preoperative evaluation did not show
distant metastasis (M0). The patient underwent an ur-
gent exploratory laparotomy. The tumor measuring 10.0
cm×4.0 cm×3.5 cm was identified at the anterior rectal
wall under the peritoneal reflection intraoperatively. A
low anterior resection using a total mesorectal excision
technique was performed, with a colostomy using
noninflamed descending colon, and the divided end of
the rectum was closed. The excised specimen contained
a poorly differentiated adenocarcinoma invading into
nonperitonealized perirectal fat with negative surgical
margins (T3). Nine regional lymph nodes were positive
for tumor extension (N2b). The tumor was classified as
stage IIIc disease based on the American Joint Commit-
tee on Cancer TNM staging system.
The patient did not receive any adjuvant radiotherapy
and chemotherapy postoperatively. In March 2012 the
patient was admitted to our department on account of
abdominal pain and distension triggered by small bowel
obstruction. A nonenhanced abdominal computed tom-
ography scan revealed enlarged para-aortic lymph nodes
measuring approximately 4 cm in diameter (Figure 1),
which compressed the left upper ureter (Figure 2). No
evidence of cerebral and visceral metastasis ortral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Nonenhanced abdominal computed tomography scan.
The scan revealed para-aortic lymph node enlargement measuring
approximately 4 cm in diameter (arrows).
Figure 3 Microscopic section of the biopsy tissue showed
abundant heterogenic cells with a neoplastic gland formation.
H & E, magnification ×200.
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tomography scan of the brain, chest, and abdomen.
In the following days, the patient complained of swelling
of her right tonsil and odynophagia. She did not report
symptoms of dysphagia or tonsillitis. Physical examination
revealed an ulcerated mass measuring about 1 cm in max-
imum diameter, on the upper part of her right palatine
tonsil. There were no palpable cervical lymph nodes. The
rest of the physical examination was unremarkable. Rou-
tine laboratory parameters including the complete blood
count, erythrocyte sedimentation rate, C-reactive protein
level, liver and pancreas enzymes, and tumor markers
(carcinoembryonic antigen, carcinoma antigen 125, car-
cinoma antigen 199, and α-fetoprotein) were all within
normal limits. A punch biopsy was taken for histological
examination, which showed a poorly differentiated adeno-
carcinoma (Figure 3). The patient underwent a palliativeFigure 2 Enlarged para-aortic lymph nodes compressed the left
upper ureter causing left ureteral obstruction and
hydronephrosis. Arrow, left ureteral obstruction.right tonsillectomy without neck dissection. Microscopic
examination of the resected specimen disclosed surface
squamous epithelium with extensive infiltration of the
tonsillar lamina propria by abundant malignant small
glandular cells (Figures 4 and 5). Immunohistochemical
analysis results of tumor cells are presented in Table 1.
These features confirmed the diagnosis of metastatic
poorly differentiated adenocarcinoma of the right palatine
tonsil identical to the colorectal primary. At the time of
submission of the present manuscript the patient was still
alive, 9 months after the diagnosis of metastatic disease.
Discussion
Metastases to tonsils from nonhematological malignant
neoplasms are rare events [3], accounting for only 0.8%Figure 4 Histopathological examination of the resected
tonsillar specimen. Histopathology showed surface squamous
epithelium with extensive infiltration of the tonsillar lamina propria
by abundant malignant small glandular cells. H & E,
magnification ×100.
Figure 5 Histopathological feature of the tonsillar tumor:
abundant malignant small glandular cells. H & E,
magnification ×200.
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[5], renal cell carcinoma [2], breast carcinoma [6], and
lung carcinoma [7] have been described as the most
common primaries of tonsillar metastases. Adenocarcin-
oma of the stomach [8] and carcinoma of the pancreas
[9] and seminomas [10] are less common primary sites.
Sporadic cases of tonsillar metastasis have been reported
from prostate carcinoma [11], gall bladder carcinoma
[12], anaplastic thyroid carcinoma [13], Merkel cell car-
cinoma [14], choriocarcinoma [15], and malignant meso-
thelioma [16].
Metastasis from a primary colorectal adenocarcinoma
to the palatine tonsil is an extremely rare event. We
searched PubMed, MEDLINE, and Google Scholar, from
inception to December 2012, using the terms ‘colorectal/
colon/colonic/rectum/rectal’; ‘cancer/ carcinoma/adeno-
carcinoma’; ‘palatine tonsil/tonsil’; and ‘metastasis’. The
literature was limited to English-language case reports.Table 1 Immunohistochemical analysis results of palatine
tonsillar tumor cells
Antibody P/N Antibody P/N Antibody P/N
bcl-6 – CD56 – EMA +++
CD1a – CD79a – Granzyme B –
CD10 – CDX-2 +++ mum-1 –
CD138 + CK20 ++ p63 –
CD20 – CK34βE12 – Perforin –
CD3 – CK5/6 – S100 –
CD45-LCA – CK7 – TdT –
CD45Ro – CKpan ++ villin +++
P/N positive/negative, CK cytokeratin, EMA epithelial membrane antigen, mum-1,
melanoma-associated antigen (mutated) 1 TdT terminal deoxynucleotidyl
transferase, –, no cells positive by immunohistochemistry (IHC); ±, sometimes
weak positive, sometimes negative by IHC; +, <25% of cells positive by IHC;
++, 25 to 50% of cells positive by IHC; +++, >50% of cells positive by IHC.References of included articles were also searched. Only
10 cases have been documented previously. We present
a summary of all these 10 cases, as well as the present
case, to highlight their clinicopathological profiles
(Table 2). In a total of 11 patients, the age ranged from
36 to 81 years (mean: 53.5 years; median: 53 years), hav-
ing a male-to-female ratio of 1.75:1 (7 vs. 4). In our case,
the patient was a 37-year-old woman with a primary rec-
tal adenocarcinoma that had metastasized to the right
palatine tonsil. This is the youngest female patient to be
reported. The metastases to palatine tonsils have a ten-
dency to manifest unilaterally, while the left side (7/11)
was more commonly involved than the right (4/11). In-
volvement of both sides was not observed. Contradictor-
ily, it had been reported that malignant melanoma
metastatic to the tonsil usually manifests bilaterally [2,8].
Of the 11 cases, seven patients had enlarged cervical
lymph nodes when the palatine tonsil mass was found,
while seven patients had primary lesions with metastatic
regional lymph nodes, and one patient had metastatic
evidence in the liver, two patients in the lung, three pa-
tients in the brain, three patients in bone, two patients
in the mediastinum, two patients in the subcutis, and
one patient in the axilla. Metastatic palatine tonsillar
adenocarcinoma is a systematic malignancy that harbors a
poor prognosis irrespective of the differentiation of the
primary tumor and stage of the disease. Even though only
10 cases have been reported, the life expectancy ranged
from 6 to 15 months, no matter whether the patient is
treated by palliative chemoradiotherapy or tonsillectomy.
In the metastatic process, tonsillar involvement could
either be the first station or a part of widespread system-
atic distant metastases. Although the pathway by which
malignancies metastasized to the tonsil remains contro-
versial and difficult to determine, some hypotheses have
been built. Brownson and colleagues suggested that
retrograde cervical lymphatic spread through the thor-
acic duct may be a potential mechanism, since the palat-
ine tonsil does not have afferent lymphatic vessels [2].
On the other hand, hematogenous spread to the tonsil
may occur through the systematic arterial blood flow
passing through the lungs. Or tumor cells can reach the
brain or head and neck region bypassing the lungs via
venous blood flow through Batson’s plexus [1]. In the
present case, evidence of metastases to the liver, lungs,
brain, and bone were not observed and no cervical
lymphadenopathy was palpated –metastasis to the uni-
lateral palatine tonsil through Batson’s plexus may there-
fore be a more reasonable explanation.
Malignancies of the palatine tonsil are unusual. Squa-
mous epithelial carcinomas and lymphomas are generally
observed in this area. In the present case, the palatine ton-
sillar tumor cells shown a glandular epithelial phenotype
histologically (Figure 5), and were negative for both









1 [17] F/55 Right Rectum Well NA 84 Mediastinum NA
2 [18] M/65 Left Transverse
colon
Poorly NA 0 Para-aortic LN, bone,
scalp
6
3 [19] M/36 Right Rectum Signet-ring cell Dukes C 24 NA 15 alive
4 [20] F/81 Left Hepatic flexure Moderately NA 0 Lung, liver, bone 12
5 [21] M/53 Right Rectum Poorly Dukes C2 24 Brain 6 alive
6 [22] M/45 Left Rectum Signet-ring cell NA 0 Subcutaneous, bone 6
7 [23] M/44 Left Cecum Signet-ring cell NA 0 NA NA
8 [24] M/53 Left Ascending
colon
Moderately T3N1M0 19 Brain 13 alive
9 [1] F/76 Left Splenic flexure Signet-ring cell T3N2M0 12 Brain, right axilla NA
10 [25] M/43 Left Left colon Moderately T4aN2bM0 12 Lung, mediastinum NA
Present case F/37 Right Rectum Poorly T3N2bM0 5 Para-aortic LN 9 alive
F female, M male, Well, well differentiated adenocarcinoma; moderately, moderately differentiated adenocarcinoma; poorly, poorly differentiated adenocarcinoma;
Signet-ring cell, signet-ring cell carcinoma; interval, time between the diagnosis of colorectal carcinoma and the development of metastasis to the palatine tonsil;
LN lymph nodes, NA not available.
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34βE12, CK5/6, and p63] and lymphoma markers [bcl-6,
CD1a, CD10, CD20, CD3, CD45-LCA, CD45Ro, CD56,
CD79a, granzyme B, melanoma-associated antigen (mu-
tated) 1, perforin, and terminal deoxynucleotidyl transfer-
ase] immunohistochemically (Table 1). Since there is no
glandular epithelium in the palatine tonsil, a metastatic
adenocarcinoma should be incorporated into the differen-
tial diagnosis. Adenocarcinoma of unknown primary often
occurs in clinical practice. Even in the era of advanced im-
aging techniques and molecular tests, identification of the
site of origin for metastatic adenocarcinoma frequently
poses a challenge to clinicians and pathologists, and may
lead to different therapeutic consequences. Immunohisto-Figure 6 Tumor cytoplasm was cytokeratin 20-positive.
3,3′-Diaminobenzidine, magnification ×100.chemical analysis remains a mainstay choice in identifying
the histological origin of palatine tonsillar tumor with an
occult primary. Although only few of tumor markers are
very specific and have high sensitivity, several markers
with moderate specificity are available, and when used in
panels the discriminating capacity of these markers may
be sufficient. The different expression patterns of CK20,
CK7, CDX-2 and villin can be useful [26,27]. Given that
78% of adenocarcinomas of the upper gastrointestinal
tract express both CK20 and CK7, most colorectal adeno-
carcinomas are positive for CK20 but negative for CK7
[26,27]. Further, metastatic lung adenocarcinoma shows
a respiratory-type phenotype (CK20–/CK7+/ CDX-2–/
villin–), while metastatic colorectal adenocarcinomaFigure 7 Tumor cell nucleus was positive for CDX-2.
3,3′-Diaminobenzidine, magnification ×100.
Figure 8 Homogeneous diffuse membrane and cytoplasm
uptake of anti-villin antibodies in tumor cells. 3,3′-Diaminoben-
zidine, magnification ×100.
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2+/villin+, as in our case; Figures 6, 7, 8 and 9) [28].Conclusions
Metastatic palatine tonsil cancer from a primary colorec-
tal adenocarcinoma is an extremely rare malignancy with
a poor prognosis, and may lay a pitfall for clinicians. Im-
munohistochemical examination should therefore be
performed. Immunomarkers including CK20, CK7,
CDX-2, and villin are facilities in immunohistochemistry
examination. The route of metastasis to the tonsil re-
mains unclear and should been studied further.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanyingFigure 9 Tumor cells were negative for cytokeratin 7.
3,3′-Diaminobenzidine, magnification ×100.images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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